TENAX THERAPEUTICS, INC. Cash
TENAX THERAPEUTICS, INC. (TENX) had Cash of $345.00 thousand as of 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:Cash · last filed 2023-11-13
- 2023-09-30: Cash $345.00K.
- 2023-06-30: Cash $13.40M.
- 2023-03-31: Cash $14.40M.
- 2022-12-31: Cash $2.10K; Cash as first filed $2.10M.
| Period end | Cash | Cash as first filed |
|---|---|---|
| 2023-09-30 | $345.00K 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $13.40M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $14.40M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $2.10K 10-Q · filed 2023-08-14 | $2.10M 10-K · filed 2023-03-31 |
| 2021-12-31 | $5.60M 10-K · filed 2023-03-31 | |
| 2020-12-31 | $6.70M 10-K · filed 2022-03-29 | |
| 2019-12-31 | $5.40M 10-K/A · filed 2021-04-16 | |
| 2018-12-31 | $12.90M 10-K · filed 2020-03-30 | |
| 2017-12-31 | $9.50M 10-K · filed 2019-04-01 | |
| 2016-12-31 | $21.90M 10-K · filed 2018-04-02 | |
| 2015-12-31 | $38.20M 10-K · filed 2017-03-16 | |
| 2015-04-30 | $48.10M 10-KT · filed 2016-03-14 | |
| 2014-04-30 | $58.30M 10-KT · filed 2016-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |